Literature DB >> 34766302

Cell-Penetrating Peptides as Carriers for Transepithelial Drug Delivery.

Danai Anastasia Panou1, Ragna Guldsmed Diedrichsen1, Mie Kristensen2, Hanne Mørck Nielsen3.   

Abstract

This chapter describes the use of cell-penetrating peptides (CPPs) as carriers for transepithelial delivery of therapeutic peptides. Assessment of transepithelial peptide permeation and the mechanisms of action that permeability enhancing drug carriers exert on the epithelium requires subtle sample preparation and analysis by orthogonal methods. Here, the preparation and use of CPP-insulin physical mixture samples including the quantification of insulin by enzyme-linked immunosorbent assay (ELISA) is described. In addition, effects of CPPs on the epithelium and its barrier properties immediately upon exposure and after a recovery period are evaluated by epithelial cell viability, transepithelial electrical resistance, immunostaining of the tight junction associated zonula occludens (ZO-1) protein, and actin cytoskeleton staining.
© 2022. The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Actin cytoskeleton; Caco-2; Epithelial cell viability; Epithelial recovery; Insulin; Oral drug delivery; Peptide permeation; Sample preparation; Tight junction

Mesh:

Substances:

Year:  2022        PMID: 34766302     DOI: 10.1007/978-1-0716-1752-6_24

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  37 in total

Review 1.  Challenges in oral peptide delivery: lessons learnt from the clinic and future prospects.

Authors:  Joël Richard
Journal:  Ther Deliv       Date:  2017-07

2.  Penetratin-Mediated Transepithelial Insulin Permeation: Importance of Cationic Residues and pH for Complexation and Permeation.

Authors:  Mie Kristensen; Henrik Franzyk; Mia Thorne Klausen; Anne Iversen; Jesper Søborg Bahnsen; Rikke Bjerring Skyggebjerg; Vito Foderà; Hanne Mørck Nielsen
Journal:  AAPS J       Date:  2015-05-20       Impact factor: 4.009

3.  An ingestible self-orienting system for oral delivery of macromolecules.

Authors:  Alex Abramson; Ester Caffarel-Salvador; Minsoo Khang; David Dellal; David Silverstein; Yuan Gao; Morten Revsgaard Frederiksen; Andreas Vegge; František Hubálek; Jorrit J Water; Anders V Friderichsen; Johannes Fels; Rikke Kaae Kirk; Cody Cleveland; Joy Collins; Siddartha Tamang; Alison Hayward; Tomas Landh; Stephen T Buckley; Niclas Roxhed; Ulrik Rahbek; Robert Langer; Giovanni Traverso
Journal:  Science       Date:  2019-02-08       Impact factor: 47.728

Review 4.  Using peptides to increase transport across the intestinal barrier.

Authors:  M Sánchez-Navarro; J Garcia; E Giralt; M Teixidó
Journal:  Adv Drug Deliv Rev       Date:  2016-05-04       Impact factor: 15.470

Review 5.  Chemically modified peptides and proteins - critical considerations for oral delivery.

Authors:  Stephen T Buckley; František Hubálek; Ulrik Lytt Rahbek
Journal:  Tissue Barriers       Date:  2016-03-03

Review 6.  Advances in oral peptide therapeutics.

Authors:  Daniel J Drucker
Journal:  Nat Rev Drug Discov       Date:  2019-12-17       Impact factor: 84.694

Review 7.  Animal models for evaluation of oral delivery of biopharmaceuticals.

Authors:  Stine Harloff-Helleberg; Line Hagner Nielsen; Hanne Mørck Nielsen
Journal:  J Control Release       Date:  2017-09-19       Impact factor: 9.776

8.  Cellular Effects and Delivery Propensity of Penetratin Is Influenced by Conjugation to Parathyroid Hormone Fragment 1-34 in Synergy with pH.

Authors:  Mie Kristensen; Line Hagner Nielsen; Kinga Zor; Anja Boisen; Malene Vinther Christensen; Jens Berthelsen; Hanne Mørck Nielsen
Journal:  Bioconjug Chem       Date:  2018-01-09       Impact factor: 4.774

Review 9.  Oral delivery of anti-diabetes therapeutics using cell penetrating and transcytosing peptide strategies.

Authors:  Sahrish Rehmani; James E Dixon
Journal:  Peptides       Date:  2018-02       Impact factor: 3.750

Review 10.  Safety and efficacy of sodium caprate in promoting oral drug absorption: from in vitro to the clinic.

Authors:  Sam Maher; Thomas W Leonard; Jette Jacobsen; David J Brayden
Journal:  Adv Drug Deliv Rev       Date:  2009-10-01       Impact factor: 15.470

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.